BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
84 results:

  • 1. Discriminative and prognostic significance of LINC00623 for lung adenocarcinoma.
    Lin Y; Dong C; Zhang J; Zhu Y
    Ann Biol Clin (Paris); 2024 Feb; 81(6):591-601. PubMed ID: 38391164
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Menthol induces apoptosis and inhibits proliferation and migration of nonsmall cell lung carcinoma in vitro and in vivo through akt pathway.
    Liu Z; Li C; Mu L; Hu H; Qin X
    Clin Respir J; 2023 Dec; 17(12):1265-1275. PubMed ID: 38012058
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via PI3K/akt/mTOR and autophagy pathways.
    Xu H; Wang J; Al-Nusaif M; Ma H; Le W
    Cell Prolif; 2024 Mar; 57(3):e13560. PubMed ID: 37850256
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BATF2 inhibits PD-L1 expression and regulates CD8+ T-cell infiltration in non-small cell lung cancer.
    Liu J; Li J; Tuo Z; Hu W; Liu J
    J Biol Chem; 2023 Nov; 299(11):105302. PubMed ID: 37777155
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [PHF5A Promotes Proliferation and Migration of Non-small cell lung cancer 
by Regulating of PI3K/akt Pathway].
    Wang H; Liu F; Bai C; Xu N
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):10-16. PubMed ID: 36792075
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Relationship between the microRNAs and PI3K/akt/mTOR axis: Focus on non-small cell lung cancer.
    Lin Y; Zhang L; Ding X; Chen C; Meng M; Ke Y; Wang W
    Pathol Res Pract; 2022 Nov; 239():154093. PubMed ID: 36183437
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-29b Regulates lung cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/akt Pathway.
    Zhang H; Wang R; Deng Q
    Comput Math Methods Med; 2022; 2022():3110330. PubMed ID: 36003920
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access.
    Florez MA; Kemnade JO; Chen N; Du W; Sabichi AL; Wang DY; Huang Q; Miller-Chism CN; Jotwani A; Chen AC; Hernandez D; Sandulache VC
    Cancer Res Commun; 2022 Jul; 2022(8):806-13. PubMed ID: 35966167
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MIR4435-2HG Is a Potential Pan-cancer Biomarker for diagnosis and Prognosis.
    Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
    Front Immunol; 2022; 13():855078. PubMed ID: 35784328
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LINC00665: An Emerging Biomarker for cancer Diagnostics and Therapeutics.
    Zhong C; Xie Z; Shen J; Jia Y; Duan S
    Cells; 2022 May; 11(9):. PubMed ID: 35563845
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. LINC00963: A potential cancer diagnostic and therapeutic target.
    Xie Z; Zhong C; Shen J; Jia Y; Duan S
    Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.
    Vadla GP; Daghat B; Patterson N; Ahmad V; Perez G; Garcia A; Manjunath Y; Kaifi JT; Li G; Chabu CY
    Sci Rep; 2022 Apr; 12(1):6693. PubMed ID: 35461372
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular target therapeutics of EGF-TKI and downstream signaling pathways in non-small cell lung cancers.
    Liu CY; Lin HF; Lai WY; Lin YY; Lin TW; Yang YP; Tsai FT; Wang CL; Luo YH; Chen YM; Hsu PK; Kai LJ; Kiat AOH; Chien Y; Chiou SH; Wang CY
    J Chin Med Assoc; 2022 Apr; 85(4):409-413. PubMed ID: 35383703
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the akt pathway.
    Zheng J; Zheng Y; Li W; Zhi J; Huang X; Zhu W; Liu Z; Gong L
    Clin Chim Acta; 2022 May; 530():66-73. PubMed ID: 35245482
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A 10-year retrospective study of lung cancer in Uganda.
    Bogere N; Bongomin F; Katende A; Omaido BA; Namukwaya E; Mayanja-Kizza H; Walusansa V
    BMC Cancer; 2022 Feb; 22(1):204. PubMed ID: 35197014
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting Neuregulin 1 (NRG1): A Novel Biomarker for Non-small-cell lung cancer.
    Fang C; Kang B; Zhao P; Ran J; Wang L; Zhao L; Luo H; Tao L
    J Environ Pathol Toxicol Oncol; 2021; 40(4):61-72. PubMed ID: 34936301
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Activation of PI3K/akt Pathway Is a Potential Mechanism of Treatment Resistance in small cell lung cancer.
    Jin Y; Chen Y; Tang H; Hu X; Hubert SM; Li Q; Su D; Xu H; Fan Y; Yu X; Chen Q; Liu J; Hong W; Xu Y; Deng H; Zhu D; Li P; Gong Y; Xia X; Gay CM; Zhang J; Chen M
    Clin Cancer Res; 2022 Feb; 28(3):526-539. PubMed ID: 34921019
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
    Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
    Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.